Kc Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Kc Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $265,081 - $310,508	-4,480 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $29,345 - $31,957	-474 Reduced 9.57%	4,480 $299,000
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $19,878 - $22,357	335 Added 7.25%	4,954 $313,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $47,520 - $53,848	-823 Reduced 15.12%	4,619 $287,000
Q2 2020 Aug 18, 2020	BUY	$54.82 - $64.09 $298,330 - $348,777	5,442 New	5,442 $320,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $110B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kc Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kc Investment Advisors, LLC with notifications on news.